Portfolio company
STipe Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops drugs targeting protein-protein interactions within the STING pathway to treat cancer and autoimmune diseases for healthcare institutions and pharmaceutical firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Redona Therapeutics
This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
EXO Therapeutics
This biotechnology company develops small-molecule drugs targeting enzyme exosites for healthcare institutions and pharmaceutical partners to treat oncology and inflammatory diseases.
Accipiter Biosciences
Accipiter Biosciences develops custom-engineered protein therapies using computational design to treat complex diseases like cancer and autoimmune disorders for the healthcare sector.
Curve Therapeutics
This biotechnology company develops small molecule and cyclic peptide drugs for pharmaceutical partners and patients to treat cancer, immunology and inflammatory diseases.
T-Therapeutics
The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.
Nuage Therapeutics
This company develops drug screening assays and small-molecule therapies targeting intrinsically disordered proteins to treat aggressive cancers for the healthcare and pharmaceutical industries.
Eigen Therapeutics
The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.
